Transient silencing of hypermutation preserves B cell affinity during clonal bursting.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 40108454.
- Also identified by DOI 10.1038/s41586-025-08687-8 and PMC identifier 12058519.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
In the course of antibody affinity maturation, germinal centre (GC) B cells mutate their immunoglobulin heavy- and light-chain genes in a process known as somatic hypermutation (SHM)<sup>1-4</sup>. Panels of mutant B cells with different binding affinities for antigens are then selected in a Darwinian manner, which leads to a progressive increase in affinity among the population<sup>5</sup>. As with any Darwinian process, rare gain-of-fitness mutations must be identified and common loss-of-fitness mutations avoided<sup>6</sup>. Progressive acquisition of mutations therefore poses a risk during large proliferative bursts<sup>7</sup>, when GC B cells undergo several cell cycles in the absence of affinity-based selection<sup>8-13</sup>. Using a combination of in vivo mouse experiments and mathematical modelling, here we show that GCs achieve this balance by strongly suppressing SHM during clonal-burst-type expansion, so that a large fraction of the progeny generated by these bursts does not deviate from their ancestral genotype. Intravital imaging and image-based cell sorting of a mouse strain carrying a reporter of cyclin-dependent kinase 2 (CDK2) activity showed that B cells that are actively undergoing proliferative bursts lack the transient CDK2<sup>low</sup> 'G0-like' phase of the cell cycle in which SHM takes place. We propose a model in which inertially cycling B cells mostly delay SHM until the G0-like phase that follows their final round of division in the GC dark zone, thus maintaining affinity as they clonally expand in the absence of selection.
Medical subject headings
- B-Lymphocytes
- Somatic Hypermutation, Immunoglobulin
- Antibody Affinity
- Clone Cells
- Gene Silencing